Fatigue Is Associated With Serum Interleukin-6 Levels and Symptoms of Depression in Patients on Chronic Hemodialysis

被引:97
|
作者
Bossola, Maurizio [1 ]
Di Stasio, Enrico [2 ]
Giungi, Stefania [1 ]
Rosa, Fausto [1 ]
Tazza, Luigi [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Transplantat & Dialysis, Hemodialysis Serv, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Clin Chem, I-00168 Rome, Italy
关键词
Hemodialysis; fatigue; inflammation; interleukin-6; depression; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; SYSTEMIC INFLAMMATION; CANCER-PATIENTS; DIALYSIS; DISEASE; STRESS; TOCILIZUMAB; ACTIVATION;
D O I
10.1016/j.jpainsymman.2014.07.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Little is known about activated immune-inflammatory pathways and interleukin-6 (IL-6) in the development of fatigue and/or depression in patients with end-stage renal disease on chronic hemodialysis (HD). Objectives. To evaluate the possible correlation between fatigue and serum levels of IL-6 in patients on chronic HD. Methods. One hundred HD patients were assessed for the presence of fatigue using the SF-36 Vitality subscale and were administered the Beck Depression Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), the Mini-Mental State Examination (MMSE), the activities of daily living (ADL), and the instrumental activities of daily living (IADL). We also calculated the time of recovery after hemodialysis (TIRD) and the number/severity of comorbidities using the Charlson Comorbidity Index (CCI). Laboratory parameters were measured as well as serum IL-6. Results. Forty-three patients constituted the fatigued group and 57 the nonfatigued group. Age, CCI, BDI, HARS, and TIRD were significantly higher in fatigued patients than in the nonfatigued patients. Conversely, the scores of ADL, IADL, and MMSE were significantly lower in fatigued than in nonfatigued patients. Serum IL-6 levels (pg/mL) were higher in the fatigued group (5.1 +/- 3.4) than in the nonfatigued group (1.6 +/- 1.5; P < 0.001); serum albumin and creatinine levels were significantly lower. Twenty-six patients (26%) had no symptoms of depression (BDI score < 10), and 74 patients (74%) had symptoms of depression (BDI score > 9). Patients with a BDI score > 9 were older; had a higher CCI; a lower MMSE; a higher TIRD; lower serum albumin, creatinine, and urea levels; and higher serum IL-6 levels. The correlation analyses showed that the score of the SF-36 Vitality subscale was associated with age, dialytic age, TIRD, ADL, IADL, CCI, BDI, HARS, MMSE, serum urea, creatinine, albumin, and IL-6 levels. On multivariate general linear model analyses, with fatigue as the dependent variable and gender as a second factor, BDI and serum IL-6 levels were independently associated with the score of the SF-36 Vitality subscale. A canonical correlation analysis was performed including in the model fatigue, BDI, and biomarkers; the correlation was 0.679 (R-2 = 0.462). Fatigue, BDI, and IL-6 among biomarkers showed the strongest association with the underlying construct (standardized canonical coefficients = -0.989, 0.015, and 0.852, respectively), thus explaining a correlation of IL-6 with both depression and fatigue. Conclusion. Fatigue was significantly associated with symptoms of depression and serum IL-6 levels in patients receiving chronic HD. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 50 条
  • [41] INTERLEUKIN-6 SERUM LEVELS IN PATIENTS WITH MULTIPLE-MYELOMA
    EMILE, C
    FERMAND, JP
    DANON, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 439 - 440
  • [42] Serum interleukin-6 levels in patients with gastric carcinoma.
    Kim, YT
    Kim, YS
    Park, YJ
    Hong, SJ
    Kim, JO
    Cho, JY
    Lee, MS
    Shim, CS
    GASTROENTEROLOGY, 1999, 116 (04) : A438 - A438
  • [43] ELEVATED SERUM INTERLEUKIN-6 LEVELS IN PATIENTS WITH ACUTE HEPATITIS
    SUN, YQ
    TOKUSHIGE, K
    ISONO, E
    YAMAUCHI, K
    OBATA, H
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (03) : 197 - 200
  • [44] SERUM LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH LUNG-CANCER
    YANAGAWA, H
    SONE, S
    TAKAHASHI, Y
    HAKU, T
    YANO, S
    SHINOHARA, T
    OGURA, T
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 1095 - 1098
  • [45] Increased serum interleukin-6 levels in patients with hidradenitis suppurativa
    Xu, Haoxiang
    Xiao, Xuemin
    He, Yanyan
    Zhang, Xiaofeng
    Li, Chengrang
    Mao, Qiuxia
    Wu, Xinfeng
    Wang, Baoxi
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2017, 34 (01): : 82 - 84
  • [46] Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease
    Tangkijvanich, P
    Vimolket, T
    Theamboonlers, A
    Kullavanijaya, P
    Suwangool, P
    Poovorawan, Y
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2000, 18 (02): : 109 - 114
  • [47] Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer
    WojciechowskaLacka, A
    MateckaNowak, M
    Adamiak, E
    Lacki, JK
    CerkaskaGluszak, B
    NEOPLASMA, 1996, 43 (03) : 155 - 158
  • [48] Interleukin-6 Gene Polymorphisms and Serum Erythropoietin and Hemoglobin in Hemodialysis Iraqi Patients
    Al-Radeef, Mohanad Yasir
    Allawi, Ali Abdulmajid Dyab
    Fawzi, Hayder Adnan
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2018, 29 (05) : 1042 - 1049
  • [49] Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis
    Ibrahim-Achi, Z.
    de Vera-Gonzalez, A.
    Gonzalez-Delgado, A.
    Lopez-Mejias, R.
    Gonzalez-Gay, M. A.
    Ferraz-Amaro, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (08) : 1564 - 1570
  • [50] Periodontitis and serum interleukin-6 levels in the elderly
    Murata, T
    Miyazaki, H
    Senpuku, H
    Hanada, N
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2001, 54 (02) : 69 - 71